IB Communications reposted this
Hear about Terumo Blood and Cell Technologies’ cell expansion and final formulation solutions in this #FromTheFloor interview at #ESGCT24 >>>
IB Communications is a leading international communications agency specialising in healthcare and life sciences. We hold specific expertise in the biotech and biopharma sectors, including immunotherapy, regenerative medicine, ATMPs and cell and gene therapy. IB Communications has developed a unique operating manual based on strategy, creativity and influence - all underpinned by a can-do work culture. We deliver for our clients an increase in profile and visibility through a variety of media to drive commercial value, support for business goals and the creation of awareness for science, products and services. We build reputations that open doors!
External link for IB Communications
Unit 10, Parc House, 25-37 Cowleaze Road
Kingston Upon Thames, Surrey KT2 6DZ, GB
IB Communications reposted this
Hear about Terumo Blood and Cell Technologies’ cell expansion and final formulation solutions in this #FromTheFloor interview at #ESGCT24 >>>
IB Communications reposted this
🌟 Are you attending #ESGCT2024? 🌟 Our amazing team can’t wait to connect with you in Rome! We’re excited to share innovative ways to enhance control over critical points in your cell therapy research—from cell collection through expansion to the final fill and finish. Come by and check out our live demos: • Quantum Flex Demo: October 23 at 10:40 https://bit.ly/40dNAdy • Finia Demo: October 24 at 11:10 https://bit.ly/3Ac6B5z 👉 Plus, don’t miss our posters: • P0752: “Expansion of low-seed CAR T cells on a GMP-grade hollow-fiber bioreactor platform” • P0847: “Automation preserves product consistency and quality for the formulation, fill, and finish of T cell-based therapies” We look forward to exploring how we’re advancing cell therapy manufacturing with you. Let’s connect in Rome. 🔗 #CellTherapy #CGT #CellExpansion #FinalFormulation #CellCollection
IB Communications reposted this
Want to know what's driving innovation in cell and gene therapy? Check out this Drug Discovery World article featuring insights from industry experts, including Josh Ludwig, Global Commercial Director at ScaleReady. Read about the challenges and opportunities facing the sector: https://lnkd.in/eX-_e_rc Contact us to learn how ScaleReady is playing a crucial role in the future of cell and gene therapy. #CGT #Celltherapy #innovation
IB Communications reposted this
📣 PRESS RELEASE - eXmoor and Virica Biotech receive funding to improve AAV gene therapy manufacturing 📣 We are delighted to announce this collaborative Canada-UK project aimed at improving the manufacture of adeno-associated vectors (#AAV), a crucial component of #genetherapies. We will utilize Virica’s VSEs™, small molecules that have been shown to increase productivity of AAVs, leveraging our scale-up and process development expertise to identify top candidates and deploy them at commercial scale upon completion of the project next year. “We thank Innovate UK for supporting this project, which we believe will benefit not only our work but our entire industry – and most importantly, patients,” said Angela Osborne “The advisory services and funding provided by the National Research Council Canada / Conseil national de recherches Canada Industrial Research Assistance Program and our partnership with eXmoor create a great commercial opportunity to increase efficiency and reduce costs of life-saving therapies,” said Jean-Simon Diallo, co-founder and CEO of Virica Read the full press release below. https://lnkd.in/eCjf55tV
IB Communications reposted this
🚀 Reveos Automated Blood Processing System launches in the U.S. Terumo Blood and Cell Technologies is excited to announce that we have kicked off the launch of Reveos in the U.S. as we collaborate with Carter Blood Care for implementation to manufacture blood products for transfusion. When a person donates whole blood, that whole blood is usually separated into its respective components – plasma, platelets and red blood cells. Healthcare providers use the different blood components based on their needs. Reveos is the first whole blood automation device in the U.S. that can process whole blood into the three needed components in a single centrifugation cycle. This streamlined process helps maximize the yield of whole blood donations, addressing the ongoing challenges of #plateletshortages and the need for more efficient blood processing methods. "Reveos is a great fit because we’re interested in using #technology to make #blooddonationcenters more efficient. It helps us keep up with the increasing need for #blood while also making things more operationally efficient, and that, in turn, should help ease some of the labor force pressures our centers are experiencing,” says Bill Block, President and Chief Executive Officer, Blood Centers of America. ➡️https://bit.ly/3Udvu7A #Donateblood #BloodProcessing #HealthcareInnovation #BloodDonation #AutomationInHealthcare #CarterBloodCare #HealthTech #WholeBlood
IB Communications reposted this
🚀 Healthcare is transforming—are you ready to lead the change? At Kosten Digital, we empower healthcare providers, payors, and hospitals to become more agile, efficient, and innovative through cutting-edge digital solutions. Our approach focuses on four key pillars of digital transformation in healthcare: 1. Elevating Patient Care – Deliver personalized experiences and improve patient outcomes. 2. Boosting Operational Efficiency – Optimize processes, reduce costs, and streamline workflows. 3. Leveraging Data & AI – Use data-driven insights to make informed decisions and predict future needs. 4. Ensuring Compliance & Security – Safeguard sensitive data and simplify compliance across global standards. 💡 Ready to transform your organization? Whether it's creating digital products, optimizing business processes, or securing IT operations, we help you focus on what matters most—delivering exceptional healthcare. Swipe through our carousel to learn more about how we can support your digital transformation journey! ➡️ #DigitalTransformation #HealthcareInnovation #PatientCare #AIinHealthcare #Compliance #KostenDigital
IB Communications reposted this
eXmoor recently received a GMP license from the MHRA for the manufacture of cell, gene and RNA therapies at our Cell & Gene Therapy Centre in Bristol. 🧬 In this article Gillian Lewis, our QP and Chief GMP Consultant, discusses the approach we took to environmental monitoring and the key challenges faced during integration. Read more below 👇 https://lnkd.in/eFv-n7i7
IB Communications reposted this
📢 BREAKING NEWS! Germfree, a pioneering leader in modular and mobile cleanroom infrastructure, equipment and services, today announced the acquisition of Arcoplast, Inc. maker of the leading seamless primary barrier cleanroom wall and ceiling system for Life Science applications and more. The acquisition will allow Germfree to offer comprehensive facility solutions from the ground up and follows 17 years of collaboration between the companies, during which Arcoplast has supplied architectural systems for Germfree installations at over 200 facilities globally. "Coming together with Arcoplast is critical for the next phase of Germfree's growth, as we expand beyond mobile and modular spaces to fixed-facility and hybrid, turnkey facility solutions. I welcome the Arcoplast team to the Germfree family," said Kevin Kyle, CEO of Germfree. To see the revolutionary Arcoplast system in person, visit Germfree's booth #1529 this week at the 2024 International Society for Pharmaceutical Engineering (ISPE) Annual Meeting & Expo in Orlando, Florida. Read more ➡️ https://hubs.ly/Q02TfJfL0 #Germfree #Arcoplast #ModularCleanrooms #MobileCleanrooms
IB Communications reposted this
We’re thrilled to share that Kosten Digital has been featured in Genetic Engineering & Biotechnology News 🎉 The article, "Cell Therapy Developers Should Build Slowly with Artificial Intelligence", highlights the growing role of AI and how companies can leverage these tools to drive innovation in cell therapy. We're proud to contribute our insights into the transformative potential of AI in this space. Check out the full article here: 👉 https://lnkd.in/gCazimSE A big thanks to GEN for this opportunity, and to our amazing team at Kosten Digital for continuing to push the boundaries of AI and life sciences! #AI #LifeSciences #CellTherapy #Biotech #Innovation #ArtificialIntelligence #KostenDigital
IB Communications reposted this
🚀 We are incredibly proud to announce that ReiThera has successfully manufactured and shipped doses of the Marburg disease vaccine to Rwanda! 🎉 This milestone marks a crucial step forward in the global fight against this dangerous virus, and we couldn't be prouder of the impact this will have on public health. 🤝 “At ReiThera, we believe in the transformative power of global collaboration to advance science and create lasting impact. Our partnership with Sabin highlights our shared commitment to developing a life-saving vaccine against Marburg disease with a mutual goal: to save lives and ensure that even the most vulnerable communities around the world have access to vital and equitable protection” says Stefano Colloca, CEO of Reithera: “I also want to personally thank our incredible team for their hard work and dedication in successfully manufacturing and shipping the vaccine doses. Your commitment was able to truly make a difference and I couldn't be prouder of what we've achieved together." #Teamwork #ProudCEO #VaccineInnovation #GlobalHealth #ReiThera
Rwanda began dosing health workers today with investigational Sabin vaccine -- a day after it was delivered -- in efforts to fight the #Marburg outbreak that was declared on Sept. 27. The vaccines are being used in a rapid response open-label trial sponsored by the Rwanda Biomedical Centre. More here: https://lnkd.in/ef9PM5Ts REITHERA